HeartFlow
Bringing together human ingenuity and advanced technology to help combat heart disease, the #1 cause of death.
HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary arteries, enabling physicians to create more effective treatment plans for their patients.
At the heart of our mission is a commitment to making cardiovascular care easier for doctors and safer for patients. Physicians get the critical information they need without the added risks and costs of an invasive procedure.
Follow us on Twitter @HeartFlow
Follow us on LinkedIn HeartFlow, Inc.
Visit our website at www.heartflow.com
CCTA-based coronary plaque quantification and patient care - is it beneficial?
What does CCTA enable in CAD prevention and diagnosis? What does plaque quantification tell us about long term cardiovascular outcomes, and how does it inform risk prevention? Dr. Matthew Budoff discusses the clinical evidence supporting the use of CCTA-based plaque quantification in the diagnosis and management of coronary artery disease.
